M6A readers (YTHDF2, IGF2BP1, and IGF2BP3) promote the progression of bladder cancer by stabilizing SETD7 [271], KLF4 [271], FSCN1 [7], and MYC [7] mRNA and regulating JAK/STAT [275] signaling pathway activation. The gene discussed is METTL3; the disease is urinary bladder carcinoma.